Cargando…

Cases of Genito-Urinary Diseases Treated by Kava-Kava

Detalles Bibliográficos
Autor principal:	Phillips, Leslie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oliver and Boyd 1897
Materias:	Clinical Records
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5251952/

Ejemplares similares

Kava-Kava in Gonorrhœa
Publicado: (1893)

Kava, Kawa, Kava-Kava—A Powerful Anæsthetic and Spinal Depressant
Publicado: (1886)

Inflammatory sebotropic reaction associated with kava kava ingestion
por: Brown-Joel, Zoe O., et al.
Publicado: (2018)

Kava : the Pacific drug /
por: Lebot, Vincent
Publicado: (1992)

Toxicokinetics of Kava
por: Rowe, Anthony, et al.
Publicado: (2011)

Kava as a Clinical Nutrient: Promises and Challenges
por: Bian, Tengfei, et al.
Publicado: (2020)

Opportunities and Challenges of Kava in Lung Cancer Prevention
por: Freeman, Breanne, et al.
Publicado: (2023)

Hepatotoxicity Induced by “the 3Ks”: Kava, Kratom and Khat
por: Pantano, Flaminia, et al.
Publicado: (2016)

An Updated Review on the Psychoactive, Toxic and Anticancer Properties of Kava
por: Soares, Rita B., et al.
Publicado: (2022)

Enhanced efficacy and reduced side effects of diazepam by kava combination
por: Tawfiq, Rasha A., et al.
Publicado: (2014)

Kava-induced acute cutaneous toxicity: An increasingly recognized characteristic clinicohistologic pattern
por: Rzepecki, Alexandra K., et al.
Publicado: (2018)

Fleming on the Genito-Urinary Organs
Publicado: (1877)

On Genito-Urinary Fistula in the Female
Publicado: (1866)

Measuring the Chemical and Cytotoxic Variability of Commercially Available Kava (Piper methysticum G. Forster)
por: Martin, Amanda C., et al.
Publicado: (2014)

A UHPLC-UV Method Development and Validation for Determining Kavalactones and Flavokavains in Piper methysticum (Kava)
por: Tang, Yijin, et al.
Publicado: (2019)

Kava constituents exert selective anticancer effects in oral squamous cell carcinoma cells in vitro
por: Celentano, Antonio, et al.
Publicado: (2020)

Ex vivo and in vitro inhibitory potential of Kava extract on monoamine oxidase B activity in mice
por: Krum, Bárbara Nunes, et al.
Publicado: (2021)

Kava for the treatment of generalised anxiety disorder (K-GAD): study protocol for a randomised controlled trial
por: Savage, Karen M., et al.
Publicado: (2015)

Evaluation of Anti-Convulsive Properties of Aqueous Kava Extract on Zebrafish Using the PTZ-Induced Seizure Model
por: Jaiswal, Yogini, et al.
Publicado: (2020)

Flavokawains A and B in Kava, Not Dihydromethysticin, Potentiate Acetaminophen-Induced Hepatotoxicity in C57BL/6 Mice
por: Narayanapillai, Sreekanth C., et al.
Publicado: (2014)

Kavain, the Major Constituent of the Anxiolytic Kava Extract, Potentiates GABA(A) Receptors: Functional Characteristics and Molecular Mechanism
por: Chua, Han Chow, et al.
Publicado: (2016)

Neuroimaging Insights: Kava’s (Piper methysticum) Effect on Dorsal Anterior Cingulate Cortex GABA in Generalized Anxiety Disorder
por: Savage, Karen, et al.
Publicado: (2023)

Driving following Kava Use and Road Traffic Injuries: A Population-Based Case-Control Study in Fiji (TRIP 14)
por: Wainiqolo, Iris, et al.
Publicado: (2016)

Biological Activity, Hepatotoxicity, and Structure-Activity Relationship of Kavalactones and Flavokavins, the Two Main Bioactive Components in Kava (Piper methysticum)
por: Wang, Yingli, et al.
Publicado: (2021)

Kava root extracts hinder prostate cancer development and tumorigenesis by involvement of dual inhibition of MAO-A and LSD1
por: Li, Xuesen, et al.
Publicado: (2021)

An Account of the Medicinal Properties, &c. of the Kava Shrub (Piper Methisticum), Gambir (Nauclea Gambir), and the Ignatia Amara, or St. Ignatius' Bean
por: Bennett, George
Publicado: (1832)

Reducing tobacco-associated lung cancer risk: a study protocol for a randomized clinical trial of AB-free kava
por: Xing, Chengguo, et al.
Publicado: (2023)

Genito-Urinary Diseases.—Gonarthritis
por: Daggett, B. H., et al.
Publicado: (1898)

Genito-Urinary Diseases—Circumcision
por: Loop, Ross G.
Publicado: (1898)

Kava Components Down-Regulate Expression of AR and AR Splice Variants and Reduce Growth in Patient-Derived Prostate Cancer Xenografts in Mice
por: Li, Xuesen, et al.
Publicado: (2012)

Genito-Urinary Therapeutics
Publicado: (1881)

Flavokawain B, a kava chalcone, inhibits growth of human osteosarcoma cells through G2/M cell cycle arrest and apoptosis
por: Ji, Tao, et al.
Publicado: (2013)

3D Imaging and metabolomic profiling reveal higher neuroactive kavalactone contents in lateral roots and crown root peels of Piper methysticum (kava)
por: Jaiswal, Yogini S, et al.
Publicado: (2020)

Genito-Urinary Surgery
Publicado: (1895)

Genito-Urinary Surgery
Publicado: (1895)

Genito-Urinary Surgery
Publicado: (1895)

Genito-Urinary Surgery
Publicado: (1894)

Dietary feeding of flavokawain A, a Kava chalcone, exhibits a satisfactory safety profile and its association with enhancement of phase II enzymes in mice
por: Li, Xuesen, et al.
Publicado: (2014)

Induction of G2M Arrest by Flavokawain A, a Kava Chalcone, Increases the Responsiveness of HER2-Overexpressing Breast Cancer Cells to Herceptin
por: Jandial, Danielle D., et al.
Publicado: (2017)

Genito-Urinary Diseases
Publicado: (1904)

Cannot write session to /tmp/vufind_sessions/sess_e3um3vk6khhnf2lm40auab9cak